Related references
Note: Only part of the references are listed.Immunohistochemical detection of mutations in the epidermal growth factor receptor gene in lung adenocarcinomas using mutation-specific antibodies
Yan Xiong et al.
DIAGNOSTIC PATHOLOGY (2013)
EGFR mutant-specific immunohistochemistry has high specificity and sensitivity for detecting targeted activating EGFR mutations in lung adenocarcinoma
W. A. Cooper et al.
JOURNAL OF CLINICAL PATHOLOGY (2013)
Immunohistochemistry to identify EGFR mutations or ALK rearrangements in patients with lung adenocarcinoma
P. Hofman et al.
ANNALS OF ONCOLOGY (2012)
Use of mutation specific antibodies to detect EGFR status in small biopsy and cytology specimens of lung adenocarcinoma
Adnan Hasanovic et al.
LUNG CANCER (2012)
A Comparison of EGFR Mutation Testing Methods in Lung Carcinoma: Direct Sequencing, Real-time PCR and Immunohistochemistry
Barbara Angulo et al.
PLOS ONE (2012)
EGFR Mutation-specific Antibodies in Pulmonary Adenocarcinoma: A Comparison With DNA Direct Sequencing
Andrea Ambrosini-Spaltro et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2012)
The usefulness of mutation-specific antibodies in detecting epidermal growth factor receptor mutations and in predicting response to tyrosine kinase inhibitor therapy in lung adenocarcinoma
Yoshiki Kozu et al.
LUNG CANCER (2011)
Including Total EGFR Staining in Scoring Improves EGFR Mutations Detection by Mutation-Specific Antibodies and EGFR TKIs Response Prediction
Shang-Gin Wu et al.
PLOS ONE (2011)
Immunohistochemical Detection of EGFR Mutation Using Mutation-Specific Antibodies in Lung Cancer
Atsuko Kitamura et al.
CLINICAL CANCER RESEARCH (2010)
Molecular Diagnosis of Activating EGFR Mutations in Non-Small Cell Lung Cancer Using Mutation-Specific Antibodies for Immunohistochemical Analysis
Akihiko Kawahara et al.
CLINICAL CANCER RESEARCH (2010)
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Assessment of EGFR Mutation Status in Lung Adenocarcinoma by Immunohistochemistry Using Antibodies Specific to the Two Major Forms of Mutant EGFR
Marie Brevet et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2010)
Novel Epidermal Growth Factor Receptor Mutation-Specific Antibodies for Non-small Cell Lung Cancer Immunohistochemistry as a Possible Screening Method for Epidermal Growth Factor Receptor Mutations
Yasufumi Kato et al.
JOURNAL OF THORACIC ONCOLOGY (2010)
Detection of EGFR mutations with mutation-specific antibodies in stage IV non-small-cell lung cancer
Sara Simonetti et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2010)
Usefulness of tissue microarrays for assessment of protein expression, gene copy number and mutational status of EGFR in lung adenocarcinoma
Marius I. Ilie et al.
VIRCHOWS ARCHIV (2010)
Mutation-Specific Antibodies for the Detection of EGFR Mutations in Non-Small-Cell Lung Cancer
Jian Yu et al.
CLINICAL CANCER RESEARCH (2009)
Screening for Epidermal Growth Factor Receptor Mutations in Lung Cancer.
Rafael Rosell et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
iTARGET: A phase II trial to assess the response to gefitinib in epidermal growth factor receptor (EGFR)-mutated non-small cell lung cancer (NSCLC) tumors
L. V. Sequist et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Epidermal growth factor receptor mutations in lung cancers
Yasushi Yatabe et al.
PATHOLOGY INTERNATIONAL (2007)
Molecular predictors of response to epidermal growth factor receptor antagonists in non-small-cell lung cancer
Lecia V. Sequist et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed
JJ Deeks et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2005)
EGF receptor gene mutations are common in lung cancers from never smokers and are associated with sensitivity of tumors to gefitinib and erlotinib
W Pao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Mutations of the epidermal growth factor receptor gene in lung cancer:: Biological and clinical implications
T Kosaka et al.
CANCER RESEARCH (2004)
EGFR mutations in lung cancer:: Correlation with clinical response to gefitinib therapy
JG Paez et al.
SCIENCE (2004)
Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib
TJ Lynch et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
The conditional relative odds ratio provided less biased results for comparing diagnostic test accuracy in meta-analyses
S Suzuki et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2004)
Measuring inconsistency in meta-analyses
JPT Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
Towards complete and,accurate reporting of studies of diagnostic accuracy: the STARD initiative
PM Bossuyt et al.
BRITISH MEDICAL JOURNAL (2003)
The diagnostic odds ratio: a single indicator of test performance
AS Glas et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2003)
Systematic reviews in health care - Systematic reviews of evaluations of diagnostic and screening
JJ Deeks
BRITISH MEDICAL JOURNAL (2001)
Diagnosing acute cardiac ischemia in the emergency department: A systematic review of the accuracy and clinical effect of current technologies
J Lau et al.
ANNALS OF EMERGENCY MEDICINE (2001)
Share Paper
